Lilly introduces global 'Innovation Starts Here' initiative

Thursday, March 1, 2012 06:02 AM

Eli Lilly has launched a global Innovation Starts Here initiative, which supports Lilly's commitment to speeding the delivery of innovative new medicines to patients around the world.

Two key components of the initiative include the Lilly Research Awards Program and the Lilly Innovation Fellowship Awards. Through both, Lilly scientists will collaborate with academic researchers on projects to aid in the advancement of Lilly's pipeline. These programs will also further Lilly's investment in R&D in Europe and the U.S.

The Innovation Fellowship Awards Program will foster post-doctoral career development through the selection of innovative research proposals. The awards establish a pre-competitive academic-industry training partnership in which a post-doctoral fellow and academic mentor are paired with a Lilly scientist to provide the industry resources that can enable the advancement of the post-doctoral scientists' research proposal.

The Research Awards Program brings together a diverse group of scientists worldwide in an effort to further the advancement of research in therapeutic areas in which Lilly has expertise, including neuroscience, cancer, diabetes and immune system disorders. The program provides a pre-competitive environment in which scientists in academia gain invaluable access to tools to conduct basic research, and Lilly scientists receive critical information to help inform the future of drug discovery and development.

"Through Innovation Starts Here, Lilly is contributing to a global collaborative culture for idea generation and innovation," said Jan Lundberg, Ph.D., executive vice president, science and technology, and president, Lilly Research Laboratories. "Collaboration is a key component to discovering innovative medicines and improving outcomes for patients. Finding innovative medicines that have clear, demonstrable value for those diseases where the unmet need is great—like diabetes and Alzheimer's disease—is not only a scientific imperative, it's an economic one as well."

Currently, Lilly is visiting academic institutions worldwide to invite them to participate in the Lilly Research Awards Program.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs